Inhibition of transforming growth factor-p attenuates brain injury and neurological deficits in a rat model of germinal matrix hemorrhage,Departments of Basic Science

Stroke

Volumn 45, Issue 3, 2014, Pages 828-834

  Manaenko, Anatol ^a   Lekic, Tim ^a   Barnhart, Margaret ^b   Hartman, Richard ^b   Zhang, John H ^a,b  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOMA LINDA UNIVERSITY   (United States)

Author keywords

Receptors; Transforming growth factor beta

Indexed keywords

2 (5 CHLORO 2 FLUOROPHENYL) 4 (4 PYRIDINYLAMINO)PTERIDINE; COLLAGENASE; GLIAL FIBRILLARY ACIDIC PROTEIN; GROWTH FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR RECEPTOR 1; UNCLASSIFIED DRUG; VITRONECTIN; PTERIDINE DERIVATIVE; SCLEROPROTEIN; SD-208; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BRAIN ATROPHY; BRAIN HEMORRHAGE; BRAIN INJURY; COGNITION; CONTROLLED STUDY; DRUG EFFECT; FUNCTIONAL ASSESSMENT; GERMINAL MATRIX HEMORRHAGE; HYDROCEPHALUS; IMMUNOFLUORESCENCE; MORPHOLOGY; MOTOR PERFORMANCE; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT MODEL; WEIGHT REDUCTION; WESTERN BLOTTING; ADULT; ANIMAL; ATROPHY; BRAIN VENTRICLE; DRUG ANTAGONISM; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; NEUROLOGIC EXAMINATION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; SURVIVAL;

RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ANIMALS; ATROPHY; BLOTTING, WESTERN; BRAIN INJURIES; CEREBRAL VENTRICLES; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; HYDROCEPHALUS; IMMUNOHISTOCHEMISTRY; INTRACRANIAL HEMORRHAGES; NERVOUS SYSTEM DISEASES; NEUROLOGIC EXAMINATION; PREGNANCY; PTERIDINES; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SURVIVAL; TRANSFORMING GROWTH FACTOR BETA; VITRONECTIN; WEIGHT LOSS;

EID: 84899138846     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.113.003754     Document Type: Article

References (38)

1. The vermont-oxford trials network: very low birth weight outcomes for 1990. Investigators of the vermont-oxford trials network database project. Pediatrics. 1993;91:540-545.
2. Kochanek KD, Kirmeyer SE, Martin JA, Strobino DM, Guyer B. Annual summary of vital statistics: 2009. Pediatrics. 2012;129:338-348.
3. Ballabh P. Intraventricular hemorrhage in premature infants: Mechanism of disease. PediatrRes. 2010;67:1-8.
4. Gomes FC, Sousa Vde O, Romao L. Emerging roles for TGF-betal in nervous system development. Int J Dev Neurosci. 2005;23:413-424.
5. Lipina R, Reguli S, NovickovS L, Podesvovd H, Brichtov S E. Relation between TGF-beta 1 levels in cerebrospinal fluid and ETV outcome in premature newborns with posthemorrhagic hydrocephalus. Childs Nerv Syst. 2010;26:333-341.
6. Douglas MR, Daniel M, Lagord C, Akinwunmi J, Jackowski A, Cooper C, et al. High CSF transforming growth factor beta levels after subarachnoid haemorrhage: Association with chronic communicating hydrocephalus. J Neurvl Neurosurg Psychiatry. 2009;80:545-550.
7. Derynck R. TGF-beta-receptor-mediated signaling. Trends Biochem Sci. 1994;19:548-553.
8. Massague J, Attisano L, Wrana JL. The TGF-beta family and its composite receptors. Trends Cell Biol. 1994;4:172-178.
9. Wrana JL, Attisano L, Wieser R, Ventura F, Massagud J. Mechanism of activation of the TGF-beta receptor. Nature. 1994;370:341-347.
10. Bernard DJ, Chapman SC, Woodruff TK. An emerging role for co-receptors in inhibin signal transduction. Mol Cell Endocrinol. 2001;180:55-62.
11. Galbreath E, Kim SJ, Park K, Brenner M, Messing A. Overexpression of TGF-beta 1 in the central nervous system of transgenic mice results in hydrocephalus. J Neuropathol Exp Neurol. 1995;54:339-349.
12. Tada T, Kanaji M, Kobayashi S. Induction of communicating hydrocephalus in mice by intrathecal injection of human recombinant transforming growth factor-beta . J. Neuroimmunol. 1994;50:153-158.
13. Ritz MF, Graumann U, Gutierrez B, Hausmann O. Traumatic spinal cord injury alters angiogenic factors and TGF-beta 1 that may affect vascular recovery. Curr Neurovasc Res. 2010;7:301-310.
14. Komuta Y, Teng X, Yanagisawa H, Sango K, Kawamura K, Kawano H. Expression of transforming growth factor-beta receptors in meningeal fibroblasts of the injured mouse brain. Cell Mol Neurobiol. 2010;30:101-111.
15. Cherian S, Whitelaw A, Thoresen M, Love S. The pathogenesis of neonatal post-hemorrhagic hydrocephalus. Brain Pathol. 2004;14:305-311.
16. Lekic T, Manaenko A, Rolland W, Krafft PR, Peters R, Hartman RE, et al. Rodent neonatal germinal matrix hemorrhage mimics the human brain injury, neurological consequences, and post-hemorrhagic hydrocephalus. Exp Neurol 2012;236:69-78.
17. Leung SY, Niimi A, Noble A, Oates T, Williams AS, Medicherla S, et al. Effect of transforming growth factor-beta receptor I kinase inhibitor 2, 4-disubstituted pteridine (SD-208) in chronic allergic airway inflammation and remodeling. J Pharmacol Exp Ther. 2006;319:586-594.
18. Manaenko A, Lekic T, Ma Q, Zhang JH, Tang J. Hydrogen inhalation ameliorated mast cell-mediated brain injury after intracerebral hemorrhage in mice. Crit Care Med. 2013;41:1266-1275.
19. Bassan H. Intracranial hemorrhage in the preterm infant: understanding it, preventing it. Clin Perinatol. 2009;36:737-62, v.
20. Li X, Miyajima M, Arai H. Analysis of TGF-beta2 and TGF-beta3 expression in the hydrocephalic H- Tx rat brain. Childs Nerv Syst. 2005;21:32-38.
21. Cherian S, Thoresen M, Silver IA, Whitelaw A, Love S. Transforming growth factor-betas in a rat model of neonatal posthaemorrhagic hydrocephalus. Neuropathol Appl Neurobiol. 2004;30:585-600.
22. Uhl M, Aulwurm S, Wischhusen J, Weiler M, Ma JY, Almirez R, et al. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo. Cancer Res. 2004;64:7954-7961.
23. Bona E, Johansson BB, Hagberg H. Sensorimotor function and neuropathology five to six weeks after hypoxia-ischemia in seven-day-old rats. Pediatr Res. 1997;42:678-683.
24. Westerga J, Gramsbergen A. The development of locomotion in the rat. Brain Res Dev Brain Res. 1990;57:163-174.
25. Georgiadis P, Xu H, Chua C, Hu F, Collins L, Huynh C, et al. Characterization of acute brain injuries and neurobehavioral profiles in a rabbit model of germinal matrix hemorrhage. Stroke. 2008;39:3378-3388.
26. Allen MC, Capute AJ. Neonatal neurodevelopmental examination as a predictor of neuromotor outcome in premature infants. Pediatrics. 1989;83:498-506.
27. Chua CO, Chahboune H, Braun A, Dummula K, Chua CE, Yu I, et al. Consequences of intraventricular hemorrhage in a rabbit pup model. Stroke. 2009;40:3369-3377.
28. Bonniaud P, Margetts PJ, Kolb M, Schroeder JA, Kapoun AM, Damm D, et al. Progressive transforming growth factor beta 1-induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor. Am J Respir Crit Care Med. 2005; 171:889-898.
29. Fathali N, Ostrowski RP, Lekic T, Jadhav V, Tong W, Tang J, et al. Cyclooxygenase-2 inhibition provides lasting protection against neonatal hypoxic-ischemic brain injury. Crit Care Med. 2010;38:572-578.
30. Egawa T, Mishima K, Egasliira N, Fukuzawa M, Abe K, Yae T, et al. Impairment of spatial memory in kaolin-induced hydrocephalic rats is associated with changes in the hippocampal cholinergic and noradrenergic contents. Behav Brain Res. 2002;129:31-39.
31. Ojemann RG, Fisher CM, Adams RD, Sweet WH, New PF. Further experience with the syndrome of "normal" pressure hydrocephalus. J Neurosurg. 1969;31:279-294.
32. Rojas JJ, Deniz BF, Miguel PM, Diaz R, Hermel Edo E, Achaval M, et al. Effects of daily environmental enrichment on behavior and dendritic spine density in hippocampus following neonatal hypoxia-ischemia in the rat. Exp Neurol. 2013;241:25-33.
33. Nakazato F, Tada T, Sekiguchi Y, Murakami K, Yanagisawa S, Tanaka Y, et al. Disturbed spatial learning of rats after intraventricular administration of transforming growth factor-beta 1. Neurol Med Chir (Tokyo). 2002;42:151-156, discussion 157.
34. Whitelaw A, Cherian S, Thoresen M, Pople I. Posthaemorrhagic ventricular dilatation: New mechanisms and new treatment. Acta Paediatr Suppl. 2004;93:11-14.
35. Baghdassarian D, Toru-Delbauffe D, Gavaret JM, Pierre M. Effects of transforming growth factor-beta 1 on the extracellular matrix and cyto- skeleton of cultured astrocytes. Glia. 1993;7:193-202.
36. van Horssen J, Bo L, Dijkstra CD, de Vries HE. Extensive extracellular matrix depositions in active multiple sclerosis lesions. Neurobiol Dis. 2006;24:484-491.
37. Yang D, Baumann JM, Sun YY, Tang M, Dunn RS, Akeson AL, et al. Overexpression of vascular endothelial growth factor in the germinal matrix induces neurovascular proteases and intraventricular hemorrhage. Sci Transl Med. 2013;5:19390.
38. Li T, Zhang P, Yuan B, Zhao D, Chen Y, Zhang X. Thrombin-induced tgf-betal pathway: A cause of communicating hydrocephalus post subarachnoid hemorrhage. Int J Mol Med. 2013;31:660-666.